Amylyx Pharmaceuticals
www.amylyx.com
4600 Eighth Ave Place East
525 οΎ– 8th Avenue SW
Calgary, AB T2P 1G1
Company Info
Year Established2013
Ticker
AMLX
Exchange
NASDAQ
Contacts
Josh CohenCo-Founder & Co-CEO
James M. Frates
CFO
Gina M. Mazzariello
CLO
Justin Klee
Co-Founder & Co-CEO
Tom Holmes
CTO
Company Description
Amylyx Pharmaceuticals is a biopharmaceutical company best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.
